Bionik Laboratories Corp. Annual Operating Income (Loss) in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Bionik Laboratories Corp. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2022.
  • Bionik Laboratories Corp. Operating Income (Loss) for the quarter ending March 31, 2023 was -$1.3M, a 7.43% increase year-over-year.
  • Bionik Laboratories Corp. Operating Income (Loss) for the twelve months ending March 31, 2023 was -$4.83M, a 51.6% increase year-over-year.
  • Bionik Laboratories Corp. annual Operating Income (Loss) for 2022 was -$4.83M, a 51.6% increase from 2021.
  • Bionik Laboratories Corp. annual Operating Income (Loss) for 2021 was -$9.97M, a 25.2% increase from 2020.
  • Bionik Laboratories Corp. annual Operating Income (Loss) for 2020 was -$13.3M, a 46.8% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$4.83M +$5.15M +51.6% Apr 1, 2022 Mar 31, 2023 10-K 2023-06-21
2021 -$9.97M +$3.36M +25.2% Apr 1, 2021 Mar 31, 2022 10-K 2023-06-21
2020 -$13.3M +$11.7M +46.8% Apr 1, 2020 Mar 31, 2021 10-K 2022-06-09
2019 -$25.1M Apr 1, 2019 Mar 31, 2020 10-K 2021-06-24
2013 -$1.45M -$515K -54.9% Apr 1, 2013 Mar 31, 2014 10-KT 2015-05-27
2012 -$937K -$933K -20821% Apr 1, 2012 Mar 31, 2013 10-KT 2015-05-27
2011 -$4.48K +$3.59K +44.5% Jan 1, 2011 Dec 31, 2011 10-K 2012-04-11
2010 -$8.07K Jan 8, 2010 Dec 31, 2010 10-K 2012-04-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.